These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6250762)

  • 41. TRPV1 antagonist capsazepine suppresses 4-AP-induced epileptiform activity in vitro and electrographic seizures in vivo.
    Gonzalez-Reyes LE; Ladas TP; Chiang CC; Durand DM
    Exp Neurol; 2013 Dec; 250():321-32. PubMed ID: 24145133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A review of 29 incidents involving 4-aminopyridine in non-target species reported to the ASPCA Animal Poison Control Center.
    McLean MK; Khan S
    J Med Toxicol; 2013 Dec; 9(4):418-21. PubMed ID: 24129835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions.
    Reddy DS; Kuruba R
    Int J Mol Sci; 2013 Sep; 14(9):18284-318. PubMed ID: 24013377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustained-release fampridine (4-aminopyridine) in multiple sclerosis: efficacy and impact on motor function.
    Rabadi MH; Kreymborg K; Vincent AS
    Drugs R D; 2013 Sep; 13(3):175-81. PubMed ID: 23873597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 4-aminopyridine toxicity: a case report and review of the literature.
    King AM; Menke NB; Katz KD; Pizon AF
    J Med Toxicol; 2012 Sep; 8(3):314-21. PubMed ID: 22782458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis].
    Husseini L; Leussink VI; Kieseier BC; Hartung HP
    Nervenarzt; 2010 Feb; 81(2):203-11. PubMed ID: 20112006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of retigabine on the neurodegeneration and extracellular glutamate changes induced by 4-aminopyridine in rat hippocampus in vivo.
    Mora G; Tapia R
    Neurochem Res; 2005 Dec; 30(12):1557-65. PubMed ID: 16362775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of 4-aminopyridine (fampridine) in demyelinating disorders.
    Hayes KC
    CNS Drug Rev; 2004; 10(4):295-316. PubMed ID: 15592580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of carbamazepine and baclofen on 4-aminopyridine-induced epileptic activity in rat hippocampal slices.
    Watts AE; Jefferys JG
    Br J Pharmacol; 1993 Mar; 108(3):819-23. PubMed ID: 8467367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The behavioral effects of phencyclidines may be due to their blockade of potassium channels.
    Albuquerque EX; Aguayo LG; Warnick JE; Weinstein H; Glick SD; Maayani S; Ickowicz RK; Blaustein MP
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7792-6. PubMed ID: 6278489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phencyclidine in low doses selectively blocks a presynaptic voltage-regulated potassium channel in rat brain.
    Bartschat DK; Blaustein MP
    Proc Natl Acad Sci U S A; 1986 Jan; 83(1):189-92. PubMed ID: 2417237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of 4-aminopyridine-poisoning after oral overdose; a proposal.
    Uges DR; Buirs B; Sangster B
    Pharm Acta Helv; 1984; 59(5-6):172-6. PubMed ID: 6739509
    [No Abstract]   [Full Text] [Related]  

  • 53. Poisoning with 4-aminopyridine: report of three cases.
    Spyker DA; Lynch C; Shabanowitz J; Sinn JA
    Clin Toxicol; 1980 Jun; 16(4):487-97. PubMed ID: 6250762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Research progress on a new potassium channel-blocking agent--4-aminopyridine].
    Zheng W; Zhang YP
    Sheng Li Ke Xue Jin Zhan; 1986 Jul; 17(3):254-8. PubMed ID: 2432655
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Site of action and active form of aminopyridines in squid axon membranes.
    Kirsch GE; Narahashi T
    J Pharmacol Exp Ther; 1983 Jul; 226(1):174-9. PubMed ID: 6306223
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.